Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Unknown × Molecular Targeted Therapy × Clear all

Phase

Status

Unknown 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1

Interventions

Cisplatin 265 Oxaliplatin 192 Carboplatin 189 Capecitabine 182 Docetaxel 174 apatinib 165 Paclitaxel 158 Bevacizumab 153 Gemcitabine 149 Radiotherapy 146 camrelizumab 145 Fluorouracil 143 Cyclophosphamide 125 Irinotecan 119 Drug Therapy 113 sintilimab 106 Etoposide 99 anlotinib 90 S 1 (combination) 88 Leucovorin 83 pembrolizumab 80 Doxorubicin 79 Pemetrexed 76 toripalimab 74 tislelizumab 73 Dexamethasone 69 Rituximab 64 Trastuzumab 63 Neoadjuvant Therapy 63 Cetuximab 61

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04193007 2019-12-10

BRATR

Second Affiliated Hospital of Nanchang University

Phase 2 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡